News

Marc Stapley, a director at Glaukos Corporation (NYSE:GKOS), executed a direct sale of 15,000 shares for a transaction value of approximately $1.9 million on Jan. 22, 2026, following the exercise of

In a move that may surprise nobody, artificial intelligence (AI) hyperscalers are planning to double down on their infrastructure spend this year. According to FactSet Research, big tech is forecast

Investors remain extremely upbeat about the outlook for artificial intelligence (AI) stocks, despite fears of an AI bubble. The likely reason is the expectation that these complex computer programs

AbbVie (NYSE: ABBV) is one of the largest pharmaceutical companies in the world. Though its portfolio spans many therapeutic areas, it is particularly well known for its work in immunology, a field

John Hanna, President and CEO of CareDx (NASDAQ:CDNA), directly sold 19,480 shares in multiple open-market transactions on Jan. 21, 2026 and Jan. 22, 2026, with an aggregate transaction value of

David Novack, President & COO of Dynavax Technologies Corporation (NASDAQ:DVAX), exercised 114,000 stock options and immediately sold the resulting shares for a transaction value of approximately

Some investors are skeptical of companies with high dividend yields, since it sometimes signals that the dividend may be unsustainable. However, plenty of high-yield dividend stocks look solid

When most people think of artificial intelligence (AI) winners, names like Nvidia or Advanced Micro Devices might come to mind. These are chip designers that are powering key AI tasks like the

Guardant Health (NASDAQ: GH) is on the rise, in more ways than one.

Shares of the precision oncology company have skyrocketed over the last six months. Guardant Health has also chalked up several

AT&T (NYSE:T), a provider of wireless, broadband, and fixed-line telecom services, closed Thursday at $25.11, up 4.32%. The stock moved higher after analyst upgrades and a strong fourth-quarter 2025

Telecom giant AT&T (NYSE: T) agreed to pay $5.75 billion last year to acquire Lumen's fiber business. The deal, which is expected to close early this year, will add 4 million passed locations and 1

Despite a few setbacks, Vertex Pharmaceuticals (NASDAQ: VRTX) performed pretty well last year, although it lagged the S&P 500. However, things could be very different in 2026. Thanks to several

Over the past five years, Novavax (NASDAQ: NVAX), a vaccine maker, lost more than 90% of its market value. Though it succeeded in its goal of launching a coronavirus vaccine, the biotech did so much

Last year, technology outperformed the other 10 sectors of the stock market and the S&P 500, delivering a 24.7% total return. A lot of those gains were driven by semiconductor stocks like Nvidia

The S&P 500 index offers a paltry 1.1% dividend yield. By that standard, even consumer products giant Procter & Gamble's (NYSE: PG) 2.8% yield looks lofty. Here's why dividend lovers may want to

New York City-based Eos Management disclosed a new position in Teleflex (NYSE:TFX) as of December 31, acquiring 30,831 shares in a transaction valued at $3.76 million based on quarter-end pricing.

UnitedHealth Group (NYSE: UNH) announced its 2025 full-year and fourth-quarter results on Tuesday, Jan. 27, 2026. Despite reporting better-than-expected earnings, UnitedHealth's stock plummeted 20%.

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and other AI stocks. To learn more, check out the short video, consider subscribing,

Shares of AT&T (NYSE: T) popped on Wednesday after the telecommunications titan announced strong subscriber growth metrics.

By the close of trading, AT&T's stock price was up more than 4%.

Image

Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, with a market cap of around $950 billion. In the past five years, the stock price has soared an incredible 400%, thanks in

It's been a miserable past three years for Pfizer (NYSE: PFE) shareholders. Although this drugmaker's stock was all the rage in the early days of the COVID-19 pandemic, as it co-created a

AT&T (NYSE:T), a provider of wireless voice and data services, broadband, and digital television, closed Wednesday at $24.08, up 4.70%. The stock moved higher after Q4 results beat EPS and revenue

One of the better-quality companies in the pharmaceutical sector, AbbVie (NYSE: ABBV) had a phenomenal year in 2025. Bolstered by numerous positive developments, the company maintained its

Shares of UnitedHealth Group (NYSE: UNH) stock crashed nearly 20% yesterday after reporting a tiny sales miss in its Q4 earnings report -- and a gigantic disappointment on profits.

Although